Abstract . Astrocytes in the hypothalamic suprachiasmatic nucleus, site of the master circadian pacemaker, play an essential role in the regulation of systemic circadian rhythms. To evaluate involvement of noradrenergic systems in regulation of circadian variation of clock-genes in astrocytes, we investigated effects of noradrenaline (NA) on expression of several clock genes in C6 glioma cells by using real-time PCR analysis. Treatment with NA (10 μ M) induced transient expression of Per1 mRNA, but not of Per2 , Bmal1 , Clock , Cry1 , or Cry2 mRNA, through activation of β 2 adrenoceptors. Action of NA was partially blocked by H-89 [protein kinase A (PKA) inhibitor] or KG-501 [inhibitor of cAMP response element binding protein (CREB)]. We found that pretreatment with genistein or PP2 (general or Src tyrosine kinase inhibitors, respectively) or LiCl [inhibitor of glycogen synthase kinase-3 β (GSK-3 β )] significantly inhibited NA-induced Per1 mRNA expression. In addition, treatment with H-89 and either genistein or LiCl completely blocked NA stimulatory effects. NA markedly induced tyrosine phosphorylation of Src and GSK-3 β via activation of β 2 adrenoceptors. Phosphorylation of GSK-3 β by NA was completely eliminated by genistein or PP2. These results primarily suggest that two distinct NA-mediating pathways, PKA-CREB and Src-GSK-3 β , play crucial roles in regulation of Per1 expression in astroglial cells.
Introduction
Nearly all mammalian organisms have developed a biological clock system marked by circadian rhythms to synchronize behavioral and physiological functions with 24-h periodicity (1) . The pacemaker of such circadian rhythms, located in the suprachiasmatic nucleus (SCN) of the hypothalamus, functions in the pivotal role of biological clock, regulating rhythmic generation of a variety of physiological functions (2) . Specific clock genes in this system have been identified and shown to have the crucial responsibility of circadian-rhythm generation. Recent studies of molecular-clock mechanisms have revealed that circadian oscillation of specific clock genes, including Period ( Per ), Cryptochrome ( Cry ), Bmal1 , and Clock , underlies coordination of circadian rhythmicity in approximately 24-h intervals and consists of a feedback loop in which clock-gene expression is suppressed periodically by the protein products of these genes (3) . Furthermore, reports have indicated that such clock genes affect downstream events by regulating rhythmic expression of clock-controlled molecules (4, 5) .
Although circadian rhythm generation in SCN is attributable to SCN neurons, evidence suggesting an astrocyte role has been proposed (6) . In fact, SCN is comprised of a heterogeneous cell population including neurons and glial cells, with astrocytes shown to exist at a rate of about 25% within the SCN (7) . One report has shown that inhibition of glial metabolism or glial-gap junctions disturbs circadian rhythms of SCN neurons (8) . Such observations have led to speculation that SCN glial cells play pivotal roles in modulating or synchronizing circadian patterns of neuronal activities in SCN. Furthermore, recent reports indicated that astrocytes themselves express circadian oscillation of clock-gene activity and that generation of such rhythms in these cells was sustained when the cells were co-cultured with explants of the adult SCN (9) . These observations therefore suggest the possibility that astrocyte circadian activity might serve some function in circadian pacemaking in SCN, with certain diffusible factor(s) produced from the SCN neurons involved in regulation of glial circadian rhythms.
Nevertheless, exactly what molecules are associated with modulation of circadian expression in astroglial clock genes is as yet not understood.
SCN molecules such as glutamate, serotonin, and pituitary adenylate cyclase activating peptide have been shown to activate clock-gene transcription (10 -12) . Furthermore, noradrenaline (NA) is a candidate compound for initiation of the cueing of clock-gene expression in astrocytes. Noradrenergic fibers and terminals also are present in the SCN (13) . Semba et al. (14) demonstrated that NA levels in rat SCN are high during periods of light and low during periods of darkness, pointing to circadian oscillation of NA levels. Moreover, NA might modulate SCN circadian rhythms by regulating expression of arginine-vasopressin and vasoactive intestinal peptides, substances hypothesized to participate in control of circadian rhythms (15) . In addition to the SCN, reports also have demonstrated that NA generates circadian-clock oscillation in peripheral organs and cells (16, 17) . Thus, since various roles of NA and several types of adrenergic receptor expression in astrocytes have been reported (18) , the possibility also exists that clock-gene expression in astroglial cells might be mediated by NA -adrenergic receptor cascades.
In this study we used C6 glioma cells, which have the potential to express astrocyte-type characteristics (19) . Since these cells exhibit circadian oscillation in clockgene expression after exposure to several reagents (20) , we felt it reasonable to try elucidating whether signaling cascades triggered after stimulation with NA also might affect clock-gene expression. As a result of testing this hypothesis, we found that treatment of C6 cells with NA led to transient increase in Per1 mRNA expression via β 2 -adrenergic receptors. Furthermore, this same reaction might be involved in activities of both protein kinase A (PKA) and the Src family of protein tyrosine kinases.
Materials and Methods

Materials
Ham's F12K medium, NA, forskolin, propranolol, CGP20712A, ICI118551, H-89, KG-501, and U73122 were obtained from Sigma Chemical Co. (St. Louis, MO, USA). PP2, KN-93, and Gö6983 were from Calbiochem (La Jolla, CA, USA). Genistein, AG213, U0126, wortmannin, SB202190, and SP600125 were purchased from Tocris Cookson (Bristol, UK). BAPTA-AM was from Dojindo Laboratories (Kumamoto). LiCl was from Nacalai Tesque (Kyoto). NA, propranolol, CGP20712A, ICI118551, H-89, or LiCl were dissolved in distilled H 2 O. AG213, U73122, genistein, PP2, KG-501, Gö6983, U0126, SB202190, SP600125, and BAPTA-AM were dissolved in DMSO. The final concentrations of all solvents for treatment of the cells were maintained at 0.5%.
Cell culture
Rat C6 glioma cells were acquired from American Type Culture Collection (Manassas, VA, USA) (CCL-107) and were maintained in Ham's F12K medium supplemented with 15% horse serum, 2.5% fetal calf serum, 100 units/ml of penicillin, and 100 μ g/ml of streptomycin in an atmosphere of 5% CO 2 / 95% air at 37°C. Twentyfour hours before each experiment, the medium was exchanged with serum-free medium to exclude the undesirable effects of serums. C6 cells between passage numbers 40 and 60 were used for all experiments.
RT-PCR analysis
Total RNAs in C6 cells, rat spinal cord, or adipose tissue were used to synthesize cDNA with MuLV reverse transcriptase (Applied Biosystems, Foster City, CA, USA) and a random hexamer primer. PCRs were performed with each specific primer indicated in a previous study (21) and AmpliTag Gold TM (Applied Biosystems) at 95°C for 10 min followed by 35 cycles of 95°C for 30 s, each annealing temperature for 30 s, and 72°C for 2 min, with a final extension at 72°C for 5 min. The resulting PCR products were analyzed on a 1.5% agarose gel and had the size expected from the known cDNA sequence.
Real-time PCR analysis
cDNA synthesized using 1 μ g of total RNA in each sample were subjected to real-time PCR assays with each specific primer and IQ TM SYBR ® Green Supermix (Biorad, Tokyo). The sequences of primers are indicated in Table 1 . Real-time PCR assays were conducted using a DNA engine Opticon 2 real-time PCR detection system (Bio-Rad). The three-step amplification protocol con-sisted of a 3 min at 95°C followed by 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. RNA quantities of target genes were calculated by the C t method. The C t values of clock genes amplification were normalized to those of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) amplification.
Western blot analysis
Cells were washed with ice-cold PBS, and solubilized in radioimmunoprecipitation assay (RIPA) buffer with protease inhibitors (100 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 20 μ g/ ml aprotinin, 20 μ g/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride). The cell lysates were further added to Laemli's buffer and boiled for 5 min. Equal amounts of protein were separated by 10% SDS-polyacrylamide gel electrophoresis and blotted onto nitrocellulose membranes. The membranes were blocked in blocking buffer for 1.5 h at room temperature and subsequently incubated with purified polyclonal antibody against Per1 (1:300; Santa Cruz Biotechnology, Santa Cruz, CA, USA), total cAMP response element binding protein (CREB) (1:1000; Cell Signaling Technology, Beverly, MA, USA), phospho-CREB (1:1000, Cell Signaling Technology), phospho-Src (pY 418 , 1:1000; Biosource, Camarillo, CA, USA), monoclonal antibody against phospho-glycogen synthase kinase-3 β (GSK-3 β ) (pY 216 , 1:1000; BD Bioscience, San Jose, CA, USA), or β -actin (1:10000, Sigma) overnight at 4°C. The membranes were washed and then incubated with a horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG antibody (Santa Cruz Biotechnology) for 1 h at room temperature. Then, the membranes were rinsed, and incubated with Luminescence reagent (Bio-rad). Finally, the membranes were exposed to X-ray film to detect the protein. For the quantification of signals, the densities of specific bands were measured with Science Lab Image Gauge (Fuji Film, Tokyo).
Statistical analyses
Data are expressed as the mean ± S.E.M. of at least three independent experiments. Differences between means were determined using a one-way analysis of variance (ANOVA) with a pairwise comparison by the Tukey-Kramer method. Differences were considered to be significant when the P -value was less than 0.05.
Results
NA significantly stimulates transient induction of Per1 expression through β 2 -adrenergic receptor activation in C6 cells
As shown in Fig. 1a , 1-h incubation of C6 cells with NA (10 μ M) induced transient augmentation of expression of only Per1 mRNA without affecting any other clock genes such as Per2 , Bmal1 , Clock , Cry1 , or Cry2 . Effects of NA (from 0.1 to 10 μ M for 1 h) on induction of Per1 mRNA expression were very likely to occur in a dose-dependent manner, as shown in Fig. 1b . Furthermore, NA also increased the expression level of Per1 protein, and this response peaked at 5 h (Fig. 1c) . These data suggest that NA exclusively induces Per1 expression in C6 cells. We therefore decided to focus on association between NA effects and regulation of Per1 mRNA expression.
We first examined types of adrenergic receptors that might play an indispensable role in NA effects on Per1 mRNA expression. As indicated in Fig. 2a , expression of α 1c -, α 2d -, β 1 -, or β 2 -adrenergic receptors was detected in C6 cells based on RT-PCR analysis. In our study, we used total RNA derived from rat spinal cord and adipose tissue (limited to β 3 ) as a positive control. We already confirmed that expression of subtypes of adrenoceptor mRNA except for β 3 was detected in rat spinal-cord tissue (21) , which thus represents a suitable positive control for examination regarding the presence of α and β adrenoceptors. We then investigated from a pharmacological perspective which of the receptor subtypes might be re- Table 1 Fig. 2b , any NA effect was completely suppressed by pretreatment with propranolol, a nonselective β -adrenergic receptor antagonist, or ICI118551, a selective β 2 antagonist. On the other hand, pretreatment with CGP20712A, prazocin or yohimbine, antagonists for β 1 , α 1 , and α 2 , respectively, had no effects on NA-induced Per1 mRNA expression (Fig. 2b) . Moreover, treatment with each of these antagonists alone failed to affect Per1 mRNA expression.
PKA -CREB pathways are partially involved in NA-induced Per1 mRNA expression
As Yagita and Okamura (22) have demonstrated, PKA-CREB is an important signaling cascade in Per1 transcription regulation. We therefore examined involvement of this pathway in NA-induced Per1 mRNA expression. Treatment with forskolin, an adenylate cyclase activator, led to induction of Per1 mRNA expression ( blocked NA effects (Fig. 3a) . Despite the fact that a high dose was used, H-89 (20 μ M) did not exhibit significantly increased inhibitory effects on NA-induced Per1 mRNA expression (Fig. 3a) . Furthermore, pretreatment with KG-501, which blocks CREB-dependent target-gene transcription through interference with binding between transcription factor and cofactors (23), significantly, but partially, inhibited NA-induced up-regulation of Per1 mRNA expression (Fig. 3b) . We next examined the phosphorylation level of CREB following stimulation by NA. Treatment with NA (10 μ M, 5 min) led to significantly increased CREB phosphorylation through stimulation of both β receptors, but not α 1 receptor (Fig. 3c) . Moreover, this process was completely suppressed by pretreatment with 10 μ M of H-89 (Fig. 3d) .
Src tyrosine kinases also contribute to NA-induced Per1 mRNA expression
Since blockade of the PKA-CREB pathway was insufficient for prevention of NA-induced Per1 mRNA expression, we sought other signal transduction cascades with potential for contribution to NA effects. As shown in Fig. 4a , treatment with genistein, an inhibitor of protein tyrosine kinases, led to significant inhibitory effects on induction of Per1 mRNA expression by NA or forskolin. Moreover, other tyrosine kinase inhibitors such as AG213 and PP2, a selective inhibitor of Src family tyrosine kinases, also exhibit significant inhibitory activity on NA effects (Table 2 and Fig. 4a ). Treatment with each type of tyrosine kinase inhibitor alone had no effect on Per1 mRNA expression. In addition, pretreatment with U0126, an inhibitor of MAP kinase kinase (MEK), led to partial reversal of NA-induced Per1 mRNA expression (Table  2) . On the other hand, as shown in Table 2 , negative results in terms of NA effects were obtained with U73122 (phospholipase C inhibitor), Gö6983 (protein kinase C inhibitor), pertussis toxin (G i/o protein inhibitor), SB202190 (p38 inhibitor), SP600125 (JNK inhibitor), BAPTA-AM (intracellular Ca 2+ chelator), KN-93 (Ca 2+ / calmodulin-dependent protein kinase II inhibitor), and wortmannin (phosphatidylinositol 3-kinase inhibitor). Moreover, we found that combined treatment with H-89 and either genistein or PP2 led to additional inhibitory effects on increased Per1 mRNA expression caused by NA or forskolin (Fig. 4a) . In contrast, pretreatment with genistein had no effect on CREB activation by NA (Fig.  4b) , suggesting that genistein actions are independent of the PKA-CREB pathway.
Because NA-induced Per1 mRNA expression was significantly blocked by a Src-specific inhibitor, we next investigated the phosphorylation level of Src tyrosine kinases following stimulation with NA. As a result, treatment with NA (10 μ M, 15 min) was found to significantly increase phosphorylation of these Src tyrosine kinases (Fig. 5a ). The increase was completely blocked by pretreatment with ICI118551 but not with H-89 (Fig. 5: b  and c) .
Tyrosine phosphorylation of GSK-3β contributes to NAinduced Per1 mRNA expression
Since GSK-3 β is known to be a substrate protein for Src tyrosine kinases and to participate in modulation of circadian rhythms (24, 25) , we next examined involvement of this enzyme in the circadian process. As represented in Fig. 6a , pretreatment with LiCl, a potent inhibitor of GSK-3 β , partially but significantly inhibited NA-induced Per1 mRNA expression. Furthermore, combined treatment with both LiCl and either H-89 or KG-501 almost completely suppressed stimulatory effects of NA on Per1 mRNA expression (Fig. 6a) . We then further examined NA effects on tyrosine phosphorylation of GSK-3 β . Phosphorylation of this enzyme at tyrosine residue (tyr 216 ), located in the kinase domain, was found to increase its activity (26) . As shown in Fig.   6b , stimulation with NA (10 μ M, 20 min) significantly enhanced tyrosine phosphorylation of GSK-3 β , an effect that was blocked by pretreatment with ICI118551, genistein, or PP2, but not H-89 (Fig. 6c) . Treatment with these inhibitors alone had no effects on the phosphorylation of GSK-3 β (Fig. 6c) . Furthermore, we confirmed that LiCl had no effect on NA-induced phosphorylation of CREB (Fig. 6d) . These observations thus indicate that Src-tyrosine kinase -GSK-3 β is involved in signaling cascades triggered following stimulation of β 2 -adrenergic receptors, as well as in regulation of Per1 mRNA expression in C6 cells.
Discussion
In this study, we have demonstrated that NA stimulated β 2 -adrenergic receptors and found that it induces expression of Per1 mRNA alone among several clock genes tested in C6 cells. This is the first study to report on NA -β 2 -adrenergic receptors mediating Per1 mRNA expression in astroglial cells. We assume that the cas- cades from NA -β 2 -adrenergic receptor activation to Per1 mRNA induction represent a restricted and specific system, with possible involvement of not only PKA-CREB but also Src tyrosine kinases -GSK-3 β -dependent pathways.
In this study, we used C6 cells as a model for astrocytes. A previous study has shown that C6 cells are a good tool for examining the underlying molecular machinery of clock gene expression because several clock genes are expressed and show the circadian oscillation after exposure to dexamethasone in these cells (20) . In addition, we and another laboratory have examined various functions of astrocytes by using C6 cells (19, 27) . Therefore, although further investigation using by a primary culture of SCN astrocytes is necessary, it is possible that the characteristics of C6 cells might reflect in the SCN astrocytes.
Our results suggest that Per1 is representative of the immediate inducible gene response to stimuli in glial cells. Induction of Per1 gene has been demonstrated to represent a crucial component of circadian-clock function in not only SCN but also other tissue and cells (17, 28) . In fact, several stimuli initiate robust and immediate increase in Per1 expression, suggesting that this process might be a key step in initiating circadian rhythms. Thus, demonstration of the signal-transduction pathways involved in regulation of Per1 mRNA induction in C6 cells might directly resolve questions surrounding roles of astrocytes in generation of such rhythms.
Several previous studies have demonstrated that NA stimulates induction of Per1 expression through α -or β -adrenergic receptors in various kinds of cells (17, 29) . Although expression of several types of adrenergic receptors was detected in C6 cells, our study found involvement of only β 2 adrenoceptors in NA-induced Per1 mRNA expression. As some reports have suggested a β 2 -adrenergic receptor link with multiple signal transduction cascades compared to other types of adrenoceptors (30, 31), we hypothesized that Per1 gene expression was regulated by a complex process. Furthermore, activation of β 2 receptors with NA might produce superior effects compared to activation with other adrenergic receptors in C6 cells. However, the hypothesis that α 1/2 -or β 1 -adrenergic systems might indirectly regulate NA-induced Per1 mRNA expression in other cells and tissues should not be entirely ruled out. The PKA-CREB signaling cascade coupled with β 2 adrenoceptors has been shown to play an important role in regulation of clock genes including Per1 in cerebellar granule cells and chondrocytes (32, 33) . In our study, this successive cascade was one of the regulatory components in NA-induced Per1 expression. However, H-89 completely suppressed NAinduced phosphorylation of CREB, with only partial inhibitory action of this reagent on Per1 -expression induction. Moreover, although stimulation of β 1 -adrenergic receptor was also associated with CREB phosphorylation, the NA-induced Per1 expression was not prevented by the β 1 -selective antagonist CGP20712A. Thus, these results, showing that blockage of this pathway was insufficient to prevent NA effects, led us to speculate about the involvement of transduction cascades other than PKA-CREB. In terms of regulation of Per1 mRNA expression, the possibility also exists that several β 2 adrenoceptor-triggered signaling cascades other than PKA-CREB contribute to regulation of clock gene mRNA expression (29, 32) . In this study, we focused on the Src family of tyrosine kinases as a candidate associated with NA effects, based on our finding that different types of tyrosine kinase inhibitors including PP2, a selective Src inhibitor, exhibited potent inhibitory effects on NA-and forskolininduced Per1 expression and that phosphorylation of Src occurred after stimulation of β 2 receptors, independent of PKA activity. These results were similar to results from a previous report by He et al. (34) demonstrating that cAMP-, but not PKA-, dependent mechanisms initiated activation of Src tyrosine kinases. Previous studies also suggested that certain types of Src tyrosine kinases such as c-Src, Fyn, and Lyn are expressed and function in C6 cells (35, 36) . These data indicate that Src tyrosine ki- nases might contribute to regulation of clock-gene expression in conjunction with β -adrenoceptor activation in C6 cells, although it is as yet unclear from our study exactly which types of Src tyrosine kinases are involved. Our observations might therefore provide new insight into involvement of these kinases in glial cell functions through clock regulation.
Our study first showed that NA triggered induction of Per1 mRNA expression through a Src-GSK-3 β -dependent cascade, as indicated in Fig. 7 . This hypothesis is supported by the observations that blockage of GSK-3 β activity by LiCl significantly inhibited NA-induced Per1 mRNA expression. In addition, NA-induced phosphorylation of GSK-3 β at tyr 216 was dependent on the activation of β 2 adrenoceptor and inhibited by either genistein or PP2. Furthermore, our results showing that U0126, a MEK inhibitor, had significant inhibitory effect on induction of Per1 by NA also support involvement of GSK-3 β , based on a previous report suggesting that MEK induces tyrosine phosphorylation of GSK-3 β in fibroblasts (37) . Phosphorylation of GSK-3 β at tyr 216 enhanced the activity of this enzyme and participates in the regulation of cell functions such as neuronal plasticity and apoptosis (24, 38) . GSK-3 β also is reported to be an important enzyme related to regulation of the mammalian circadian clock (25) , with its activation stimulated by β adrenoceptors (38) . Phosphorylation of GSK-3 β at tyr 216 is induced by Fyn, which belongs to the Src family of tyrosine kinases and is expressed in C6 cells (24) . Interaction between cAMP-PKA-CREB and Src-GSK-3 β was not observed in our study, however, because neither genistein nor LiCl generated potent effects on NA-induced CREB phosphorylation, and pretreatment with H-89 failed to affect NA-stimulated phosphorylation of Src or GSK-3 β .
Circadian proteins produced by clock genes are involved in regulation of expression of clock-controlled genes (4, 5) . Thus, the system also generates physiological rhythms in astrocyte functions. Several studies have suggested the existence of circadian changes in expression levels of glial fibrillary acidic protein (GFAP), a specific astrocyte maker, in SCN astrocytes (39, 40) . In addition, Moriya et al. (39) have demonstrated that the expression of GFAP in SCN was dramatically changed under constant lighting conditions, while that was not constant under a light-dark cycle. Another study has suggested that alteration of GFAP expression might reflect activity of astrocytes (41) , indicating the possibility that circadian rhythms of GFAP expression are correlated with those of astroglial functions. Glutamate transporter EAAT2 has also been proposed as a candidate for regulation by astrocyte circadian rhythms (4). Thus, although further investigation may be necessary, the signal cascades described in our study might plausibly participate in regulation of such clock-controlled gene expression through Per1 induction.
In conclusion, we observed two distinct signal transduction system-mediated clock gene Per1 expressions in C6 cells. The mechanism behind how circadian-rhythm generation in astroglial cells affects such rhythms in neurons is thus not well understood, but at the least, the SCN astroglial component is thought to be crucial for operation of circadian patterns of SCN neuronal activity. Thus, alteration of glial functions including intracellular Ca 2+ concentration, and expression of gliotransmitters, their receptors, or transporters via NA-mediated circadian rhythms in astrocytes might affect transmission to generate rhythms between SCN astrocytes and neurons. Therefore, our finding has the potential to contribute to enhanced understanding of circadian-rhythm generation in SCN neurons, as well as perhaps systemic circadian rhythms.
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